World Orphan Drug Congress USA 2017
community download

Creating Medicines with Real Value for Orphan Diseases

EveryLife Foundation at World Orphan Drug Congress USA 2016

Emil D. Kakkis, M.D., Ph.D., President and Founder joined us at the World Orphan Drug Congress USA 2016, to give a detailed keynote presentation on Creating Medicines with Real Value for Orphan Diseases.

How?

Investment is needed in R&D for Orphan Drugs, which is clinically a challenging area due to smaller patient populations. This challenge breeds less certainty about a drug's potential marketability. Drug costs also always end up very high, as Rare Diseases require specialized therapies - hence why working with Payers and other stakeholders is so vital. Without financial incentive, offered by legislation, it is save to say that orphan drug development would be hindered, if not halted. Can we produce lower cost drugs for rare diseases? Two possible solutions include: 

  1. Reduce the cost/time of development: e.g. Biomarkers
  2. Leverage the investment we have made in existing drugs

Download Emil's presentation to find out more about these options and other legislative updates >>

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (4,155Kb in size)